-
Pertussis toxin Workflows for Immune Signaling
2026-09-05
Use Pertussis toxin as a controlled cAMP-pathway perturbation tool for dendritic-cell phenotyping, signaling time courses, and comparative immune assays. This workflow also shows how to connect toxin-driven observations with TREM2–ERK/p38 research without confusing active toxin with a detoxified vaccine antigen.
-
Aligned Ce6 Silk Fibroin Films for Infected Wounds
2026-09-04
The reference study developed an aligned silk fibroin electrospun film with covalently conjugated Chlorin e6 for light-triggered antibacterial treatment of S. aureus-infected wounds. Its main innovation is the integration of photodynamic bacterial killing, anisotropic cell guidance, blood compatibility, and late-stage macrophage M2 polarization within one biomaterial platform.
-
SCH772984: Selective ERK1/2 Inhibitor Workflow
2026-09-04
SCH772984 provides a direct way to interrogate ERK1/2 signaling in mutation-driven cancer models, from short-term target engagement to clonogenic and xenograft studies. This workflow connects MAPK/ERK pathway inhibition with practical assays for proliferation, radioresistance, and ferroptosis while distinguishing established evidence from testable extensions.
-
Imipenem Workflows for Antibacterial Research
2026-09-03
Build more informative antibacterial assays with Imipenem by linking PBP-mediated killing, susceptibility kinetics, and immune readouts. This guide translates product properties into practical workflows for resistance studies, phagocytosis experiments, and sepsis animal model design while separating evidence-backed findings from assay recommendations.
-
Talabostat Mesylate (PT-100): Mechanism & Evidence
2026-09-03
Talabostat mesylate, also called PT-100, is an orally active inhibitor of DPP4 and fibroblast activation protein (FAP). Product and cellular evidence support target engagement and immune-stromal research applications, but the available breast-cancer xenograft result did not show statistically significant tumor-growth inhibition.
-
Ademetionine in Neurological Disorders: Review Insights
2026-09-02
The 1994 review by Bottiglieri, Hyland, and Reynolds connected impaired one-carbon metabolism with neuropsychiatric disease and evaluated ademetionine (S-adenosylmethionine; SAMe) as a potential intervention. Its main contribution was a biochemical-to-clinical framework linking methylation, monoamine signaling, vitamin B12 and folate status, depression, dementia, and remyelination, while also emphasizing the preliminary nature of much of the clinical evidence.
-
mCherry mRNA Workflows for Nanoparticle Assays
2026-09-02
Use mCherry mRNA as a quantitative reporter for nanoparticle loading, cellular delivery, and transient red fluorescent protein expression. Cap 1 capping, 5mCTP and ψUTP, and an optimized poly(A) tail make this reporter especially useful when assay sensitivity and low innate immune stimulation matter.
-
Antipyrine: A Smarter BBB Assay Control
2026-09-01
Antipyrine (1,5-dimethyl-2-phenylpyrazol-3-one) can do more than represent analgesic pharmacology: it can help researchers diagnose permeability, recovery, and barrier-integrity errors. This article translates a 2025 surrogate blood-brain barrier study into a decision framework for pharmacokinetic studies and drug metabolism research.
-
Pexmetinib: A Kinetic View of Cytokine Control
2026-09-01
Pexmetinib (ARRY-614) is more than a dual kinase inhibitor: it can serve as a mechanistic probe for separating target occupancy, p38α dephosphorylation, and cytokine output. This article translates recent structural findings into a causally resolved assay strategy for inflammation and myelodysplastic syndromes research.
-
Rapid Purification of Recombinant Annexin V
2026-08-31
Burger and colleagues developed a short, selective purification strategy for recombinant annexin V that combines mild osmotic opening of Escherichia coli with reversible calcium-dependent liposome binding and final ion-exchange chromatography. The approach produced highly pure protein suitable for electrophysiology, crystallography, electron microscopy, and related biophysical studies while reducing co-purification from bacterial disruption.
-
DCPS and m7G Regulation in Diabetic Foot Ulcers
2026-08-31
Xiao et al. identify the decapping scavenger enzyme DCPS as an m7G-related biomarker associated with impaired epithelial repair in diabetic foot ulcers. By integrating transcriptomic analysis with keratinocyte experiments, the study connects reduced DCPS to cell-cycle disruption, weaker proliferation and migration, and increased apoptosis, while also defining important limits for clinical translation.
-
IEM 1460: From AMPA Blockade to Translation
2026-08-30
IEM 1460 provides a selective way to interrogate AMPA receptor signaling, linking fast excitatory transmission to excitotoxicity and neuroprotection hypotheses. This thought-leadership analysis positions the compound as a mechanistic research tool and explains how evidence from the related dual antagonist IEM-1925 can inform, but not substitute for, IEM 1460-specific validation.
-
GS967: Cardiac Late Sodium Current Workflows
2026-08-29
GS967 is a cardiac late sodium current inhibitor for connecting pathological Na⁺ influx with prolonged repolarization, calcium mishandling, impaired relaxation, and arrhythmia. This practical guide covers ventricular myocyte recordings, aging models, isolated-heart assays, ischemia-induced arrhythmia studies, and troubleshooting strategies.
-
BMS 309403: FABP4 Inhibitor Workflow
2026-08-28
BMS 309403 provides a selective, mechanism-focused way to connect FABP4 activity with lipid accumulation, macrophage inflammation, and metabolic phenotypes. This guide translates recent SERCA2–calcineurin–FoxO1–FABP4 findings into practical cell-based workflows, controls, and troubleshooting strategies.
-
Gramine–CUL3–MTDH Axis in TNBC Ferroptosis
2026-08-28
A 2026 study identifies Gramine as a potential ferroptosis inducer that suppresses triple-negative breast cancer through a CUL3–MTDH ubiquitination mechanism. Its integrated chemical, cellular, and mouse-model experiments provide a framework for studying how target engagement and ubiquitin-pathway regulation can be connected to ferroptotic cell death.